Key result
Review synthesizes updated international guideline recommendations and unresolved challenges in medical management of CCS.
Why the study?
Significant gaps and controversies remain in the management of chronic coronary syndrome despite recent international guidelines.
This review provides an updated overview of international guidelines and individualized medical management strategies for chronic coronary syndrome, contextualized for the Asia-Pacific population.
May inform Asia-Pacific chronic coronary syndrome care amid guideline updates; leaves open resolution of controversies through targeted research.
Chronic coronary syndrome (CCS), one of the top contributors to mortality and morbidity worldwide, is an emerging entity that moves beyond the traditional view of fixed, flow-limiting epicardial stenoses as the sole cause of ischaemia to encompass a broader and more heterogeneous group of conditions. This heterogeneity underscores the importance of individualised management, guided by an assessment of each patient’s future cardiovascular risk. Despite recent international guidelines for the management of CCS, significant gaps and controversies remain. Our review, with a focus on the Asia-Pacific population, aims to highlight key updates from the latest international guidelines and explore potential directions for addressing these persistent challenges in CCS care.
No takes yet. Share an insight, caveat, or question.
Soh et al. (2026) conducted a review in Chronic coronary syndrome. Medical management was evaluated. This review highlights key updates from international guidelines and explores potential directions for addressing persistent challenges in the medical management of chronic coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: